926

524372

ORCHPHARMA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ORCHID PHARMA LIMITED Share Price Today

ORCHID PHARMA LIMITED is currently trading at ₹917.1, up by ₹71.14 from the previous close. The stock touched an intraday high of ₹935.00 and a low of ₹847.00 during the latest trading session. Over the past one year, ORCHID PHARMA LIMITED has delivered a return of 27.26%, while the stock has gained 29.41% in the last one month.

ORCHID PHARMA LIMITED performance

Today’s low Today’s high
₹ 847.00 ₹ 935.00
₹ 917.10
52 week low 52 week high
₹ 480.00 ₹ 935.00
₹ 917.10
Open Price ₹ 847.00
Prev. Close ₹ 845.95
Volume (Shares) 496587.00
Total traded value ₹ 4554.19
Upper Circuit ₹ 1015.10
Lower Circuit ₹ 676.80
info

Investment Returns

Over 1 Month 29.41% Over 3 Months 69.56% Over 6 Months 7.90% Over 1 Year 27.26%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ORCHID PHARMA LIMITED fundamentals


  • Market cap (Cr) 4,651.40
  • P/E Ratio (TTM) 102.92
  • Beta 1.27
  • Book Value / share 270.14
  • Return on equity 3.32%
  • EPS (TTM) 10.21
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 30.60
info icon alternate text
  • Market cap (Cr) 4,650.90
  • P/E Ratio (TTM) 102.92
  • Beta 1.21
  • Book Value / share 270.14
  • Return on equity 3.32%
  • EPS (TTM) 10.21
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 30.60
info icon alternate text

ORCHID PHARMA LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 237.61
Operating Expense 220.84
Net Profit 30.60
Net Profit Margin (%) 12.87
Earnings Per Share (EPS) 6.03
EBITDA 42.83
Effective Tax Rate (%) 0.00
Particulars DEC 2025 (Values in Cr)
Revenue 207.27
Operating Expense 216.57
Net Profit -5.82
Net Profit Margin (%) -2.80
Earnings Per Share (EPS) -1.15
EBITDA 6.32
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 193.52
Operating Expense 206.72
Net Profit 2.23
Net Profit Margin (%) 1.15
Earnings Per Share (EPS) 0.44
EBITDA 14.75
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 172.93
Operating Expense 170.66
Net Profit 18.20
Net Profit Margin (%) 10.52
Earnings Per Share (EPS) 3.59
EBITDA 30.11
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 237.48
Operating Expense 215.89
Net Profit 27.85
Net Profit Margin (%) 11.72
Earnings Per Share (EPS) 5.49
EBITDA 40.59
Effective Tax Rate (%) 0.00
Particulars MAR 2026 (Values in Cr)
Revenue 811.33
Operating Expense 814.79
Net Profit 45.21
Net Profit Margin (%) 5.57
Earnings Per Share (EPS) 8.91
EBITDA 94.01
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 921.93
Operating Expense 847.37
Net Profit 106.48
Net Profit Margin (%) 11.54
Earnings Per Share (EPS) 20.99
EBITDA 155.46
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 819.37
Operating Expense 758.24
Net Profit 94.75
Net Profit Margin (%) 11.56
Earnings Per Share (EPS) 19.59
EBITDA 141.07
Effective Tax Rate (%) -3.52
Particulars MAR 2023 (Values in Cr)
Revenue 665.90
Operating Expense 669.30
Net Profit 54.19
Net Profit Margin (%) 8.13
Earnings Per Share (EPS) 13.28
EBITDA 142.26
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 556.97
Operating Expense 618.75
Net Profit -4.81
Net Profit Margin (%) -0.86
Earnings Per Share (EPS) -1.18
EBITDA 66.25
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 236.35
ROE % 2.86
ROCE % 3.15
Total Debt to Total Equity 0.13
EBITDA Margin 15.73
Particulars MAR 2024 (Values in Cr)
Book Value / Share 217.06
ROE % 3.02
ROCE % 3.20
Total Debt to Total Equity 0.25
EBITDA Margin 17.32
Particulars MAR 2023 (Values in Cr)
Book Value / Share 151.92
ROE % 0.29
ROCE % 1.47
Total Debt to Total Equity 0.45
EBITDA Margin 15.46
Particulars MAR 2022 (Values in Cr)
Book Value / Share 141.81
ROE % 0.06
ROCE % -1.10
Total Debt to Total Equity 0.55
EBITDA Margin 11.27
Particulars MAR 2021 (Values in Cr)
Book Value / Share 143.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.72
EBITDA Margin 9.91
Particulars MAR 2025 (Values in Cr)
Book Value / Share 247.54
ROE % 3.32
ROCE % 3.61
Total Debt to Total Equity 0.12
EBITDA Margin 16.90
Particulars MAR 2024 (Values in Cr)
Book Value / Share 226.69
ROE % 3.15
ROCE % 3.33
Total Debt to Total Equity 0.24
EBITDA Margin 17.26
Particulars MAR 2023 (Values in Cr)
Book Value / Share 162.53
ROE % 0.81
ROCE % 2.34
Total Debt to Total Equity 0.43
EBITDA Margin 15.46
Particulars MAR 2022 (Values in Cr)
Book Value / Share 149.30
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.53
EBITDA Margin 12.06
Particulars MAR 2021 (Values in Cr)
Book Value / Share 150.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.69
EBITDA Margin 14.26
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 179.63
Total Assets 1687.91
Total Liabilities 1687.91
Total Equity 1267.28
Share Outstanding 5
Price to Book Ratio 3.14
Return on Assets (%) 5.90
Return on Capital (%) 6.91
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 266.56
Total Assets 1553.87
Total Liabilities 1553.87
Total Equity 1169.46
Share Outstanding 5
Price to Book Ratio 4.61
Return on Assets (%) 5.93
Return on Capital (%) 7.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 30.62
Total Assets 1225.20
Total Liabilities 1225.20
Total Equity 688.64
Share Outstanding 4
Price to Book Ratio 2.37
Return on Assets (%) 3.78
Return on Capital (%) 4.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.06
Total Assets 1110.56
Total Liabilities 1110.56
Total Equity 647.37
Share Outstanding 4
Price to Book Ratio 1.90
Return on Assets (%) -0.17
Return on Capital (%) -0.21
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 19.91
Total Assets 1237.25
Total Liabilities 1237.25
Total Equity 652.90
Share Outstanding 4
Price to Book Ratio 16.42
Return on Assets (%) -9.41
Return on Capital (%) -10.76
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 164.28
Total Assets 1696.58
Total Liabilities 1696.58
Total Equity 1324.04
Share Outstanding 5
Price to Book Ratio 3.14
Return on Assets (%) 6.27
Return on Capital (%) 7.11
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 257.22
Total Assets 1552.20
Total Liabilities 1552.20
Total Equity 1218.31
Share Outstanding 5
Price to Book Ratio 4.61
Return on Assets (%) 6.10
Return on Capital (%) 7.01
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 22.33
Total Assets 1223.25
Total Liabilities 1223.25
Total Equity 731.96
Share Outstanding 4
Price to Book Ratio 2.37
Return on Assets (%) 4.42
Return on Capital (%) 5.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.20
Total Assets 1094.18
Total Liabilities 1094.18
Total Equity 677.95
Share Outstanding 4
Price to Book Ratio 1.90
Return on Assets (%) -0.43
Return on Capital (%) -0.51
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.96
Total Assets 1224.46
Total Liabilities 1224.46
Total Equity 681.33
Share Outstanding 4
Price to Book Ratio 16.42
Return on Assets (%) -9.56
Return on Capital (%) -10.33
Particulars MAR 2025 (Values in Cr)
Net Income 99.46
Cash from Operations 20.15
Cash from Investing -26.93
Cash from Financing 25.22
Net change in Cash 17.50
Free Cash Flow 170.26
Particulars MAR 2024 (Values in Cr)
Net Income 89.04
Cash from Operations 125.36
Cash from Investing -312.02
Cash from Financing 167.04
Net change in Cash -18.99
Free Cash Flow 190.17
Particulars MAR 2023 (Values in Cr)
Net Income 46.31
Cash from Operations 18.63
Cash from Investing -31.21
Cash from Financing 31.16
Net change in Cash 18.29
Free Cash Flow 103.54
Particulars MAR 2022 (Values in Cr)
Net Income -1.95
Cash from Operations 94.38
Cash from Investing 112.93
Cash from Financing -216.79
Net change in Cash -11.38
Free Cash Flow 108.78
Particulars MAR 2021 (Values in Cr)
Net Income -116.53
Cash from Operations 18.66
Cash from Investing 67.20
Cash from Financing -164.98
Net change in Cash -74.19
Free Cash Flow 19.26
Particulars MAR 2025 (Values in Cr)
Net Income 106.48
Cash from Operations 28.42
Cash from Investing -37.34
Cash from Financing 25.44
Net change in Cash 15.57
Free Cash Flow 96.96
Particulars MAR 2024 (Values in Cr)
Net Income 91.52
Cash from Operations 129.99
Cash from Investing -315.80
Cash from Financing 167.06
Net change in Cash -18.01
Free Cash Flow 185.14
Particulars MAR 2023 (Values in Cr)
Net Income 54.18
Cash from Operations 13.68
Cash from Investing -26.69
Cash from Financing 31.16
Net change in Cash 17.85
Free Cash Flow 98.24
Particulars MAR 2022 (Values in Cr)
Net Income -4.80
Cash from Operations 91.47
Cash from Investing 112.93
Cash from Financing -216.79
Net change in Cash -14.30
Free Cash Flow 105.87
Particulars MAR 2021 (Values in Cr)
Net Income -117.15
Cash from Operations 19.44
Cash from Investing 67.20
Cash from Financing -164.98
Net change in Cash -73.42
Free Cash Flow 20.04
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 13.39 1.56 248.29 23.12 38.85
BLISS GVS PHARMA LTD. 438.10 35.56 3.89 4646.32 118.35 462.70
CIPLA LTD. 1388.80 29.47 3.25 112193.56 1165.55 1672.20
FERMENTA BIOTECH LTD. 338.80 14.94 2.45 997.12 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 22.66 4.17 248.29 23.12 38.85
AMRUTAJAN HEALTH LTD 557.75 25.00 4.35 1612.49 490.00 789.95
ASTRAZENECA PHARMA IND LT 8243.90 107.66 23.61 20609.75 7630.00 10653.05
BLISS GVS PHARMA LTD. 438.10 47.26 4.02 4646.32 118.35 462.70

ORCHID PHARMA LIMITED shareholding pattern

Holding
9.04%
69.83%
0.86%
20.24%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

ORCHID PHARMA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
917.10 8.41 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 868.10
  • 26 Days 772.70
  • 10 Days 841.30
  • 50 Days 716.70
  • 12 Days 831.30
  • 100 Days 690.30
  • 20 Days 795.20
  • 200 Days 729.50
849.93 PIVOT
First Support 823.92 First Resistance 871.97 Second Support 801.88 Second Resistance 897.98 Third Support 775.87 Third Resistance 920.02
RSI 81.77 ADX 76.08 MACD 58.61 Williams % R -7.37 Commodity Channel Index (CCI) 131.33
Date 2026-06-12 Week 58298.00 Same Day 138325.00 Month 48329.00
1 Year 1.27 3 Year 1.00
Over 1 Month
29.41% down
Over 1 Year
27.26% down
Over 3 Months
69.56% down
Over 3 Years
30.23% down
Over 6 Months
7.90% down
Over 5 Years
-6.59% down

ORCHID PHARMA LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
13 Sep 2012 3.0 Final 15 Sep 2012 Equity shares
19 Jul 2011 3.0 Final 21 Jul 2011 Equity shares
12 Jul 2010 10.0 Final 14 Jul 2010 Equity shares
17 Sep 2009 1.0 Final 19 Sep 2009 Equity shares
18 Sep 2008 3.0 Final 20 Sep 2008 Equity shares
12 Jul 2007 3.0 Final 15 Jul 2007 Equity shares
30 May 2006 0.0 Final 01 Jun 2006 Equity shares
13 Jul 2005 0.0 Interim 15 Jul 2005 Equity shares
Ex-Date Ex-Bonus Ratio
17 Sep 2005 15 Sep 2005 1:2
Dividend date Dividend amount Dividend type Record date Instrument type
13 Sep 2012 3.0 Final 15 Sep 2012 Equity shares
19 Jul 2011 3.0 Final 21 Jul 2011 Equity shares
12 Jul 2010 10.0 Final 14 Jul 2010 Equity shares
17 Sep 2009 1.0 Final 19 Sep 2009 Equity shares
18 Sep 2008 3.0 Final 20 Sep 2008 Equity shares
12 Jul 2007 3.0 Final 15 Jul 2007 Equity shares
30 May 2006 0.0 Final 01 Jun 2006 Equity shares
13 Jul 2005 0.0 Interim 15 Jul 2005 Equity shares
Ex-Date Ex-Bonus Ratio
17 Sep 2005 15 Sep 2005 1:2

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Orchid Pharma Ltd?

Answer Field

Orchid Pharma Ltd share price is for NSE ₹ 917.10 & for BSE ₹ 917.00 as on Jun 12 2026 03:30 PM.

What is the Market Cap of Orchid Pharma Ltd Share?

Answer Field

The market cap of Orchid Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 12 2026 03:30 PM.

What is the 52 Week High and Low of Orchid Pharma Ltd?

Answer Field

The 52 Week High and Low of Orchid Pharma Ltd for NSE is ₹ 935.00 and ₹ 480.00 and for BSE is ₹ 933.50 and ₹ 471.30.

What is 1 year return for Orchid Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 27.26%.

What is the P/E Ratio of Orchid Pharma Ltd Share?

Answer Field

As on Jun 12 2026 03:30 PM the price-to-earnings (PE) ratio for Orchid Pharma Ltd share is 102.92.

What is the PB ratio of Orchid Pharma Ltd Share?

Answer Field

As on Jun 12 2026 03:30 PM, the price-to-book (PB) ratio for Orchid Pharma Ltd share is 270.14.

How to Buy Orchid Pharma Ltd Share?

Answer Field

You can trade in Orchid Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Orchid Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Orchid Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Orchid Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|